Shareholder Information

1. Shareholding

A. Distribution of shareholder numbers

Ordinary Fully Paid Shares
Category (Size Of Holding)	Total Holders	Units	% Of Issued Capital
1-1,000	4,282	1,273,323	2.54
1,001-5,000	1,024	2,336,641	4.67
5,001-10,000	160	1,188,167	2.37
10,001-100,000	170	4,316,697	8.62
100,001 & Over	26	40,962,952	81.80
Total	5,662	50,077,780	100.00

B. Shareholdings held in less than marketable parcels

Total	Minimum Parcel Size	Holders	Units
Minimum $500.00 parcel at $13.96 per unit	36	627	11,049

C. Substantial shareholdings

Name	No. Ordinary Shares & Amercian Depository Receipts
The Bank of New York Mellon Corporation¹	4,296,472
Dr Philippe Wolgen²	3,425,222
Ender LLC³	2,340,824
As disclosed in substantial holder notice dated 24 May 2022. As disclosed in director's interest notice dated 27 November 2023. Actual shareholding on 15 August 2024 is 3,425,222. As disclosed in substantial holder notice dated 16 September 2013. Actual shareholding on 15 August 2024 is 2,590,824.

D. Voting Rights

The voting rights attaching to each class of equity securities are set out below

Ordinary Shares

Ordinary shares entitle their holder to one vote, either in person or by proxy, at a meeting of the Company
Performance Rights

Performance Rights have no voting rights

E. Largest Shareholders

Position	Name	Number of ordinary fully paid shares held	% held of issued ordinary capital
1.	HSBC Custody Nominees (Australia) Ltd	10,225,972	20.42
2.	BNP Paribas Nominees Pty Ltd ACF (Clearstream)	5,685,193	11.35
3.	BNP Paribas Nominees Pty Ltd	4,988,645	9.96
4.	J P Morgan Nominees Australia Pty Limited	3,629,550	7.25
5.	Dr Philippe Jacques Wolgen	3,425,222	6.84
6.	Citicorp Nominees Pty Limited	3,416,310	6.82
7.	Ender 1 LLC	2,590,824	5.17
8.	BNP Paribas Nominees Pty Ltd (IB AU Noms Retail Client)	2,207,904	4.41
9.	HSBC Custody Nominees (Australia) Ltd A/C2	922,480	1.84
10.	Emilino Group Pty Ltd (Emilino Super Fund)	601,447	1.20
11.	National Nominees Limited	548,778	1.10
12.	Mr Darren Michael Keamy	362,890	0.72
13.	Dr Mark Edwin Badcock	346,772	0.69
14.	Mr David William Trevorrow	229,600	0.46
15.	BNP Paribas Nominees Pty Ltd (Agency Lending A/C)	229,044	0.46
16.	Dr Dennis Wright	188,812	0.38
17.	Mr David John Lewis	185,000	0.37
18.	Mr Trent Sheldon Redding	177,370	0.35
19.	Rusty Hammer Pty Ltd (Archipelago Holdings SF A/C)	150,722	0.30
20.	Mr Simon John Bown	146,000	0.29
Totals: Top 20 Holders Of Ordinary Fully Paid Shares (Total)		40,258,535	80.39
Total Remaining Holders Balance		9,819,245	19.61

2 – Company Secretary

The name of the Company Secretary is:

Claire Newstead Sinclair

3 – Registered Office

The principle registered office in Australia is:

Level 22, 535 Bourke Street
Melbourne, VIC 3000, Australia

Telephone: +61 3 9660 4900
Fax: +61 3 9660 4999
Email: [email protected]
Website: https://www.clinuvel.com

4 – Register of Securities

Computershare Investor Services Pty Ltd
Yarra Falls, 453 Johnston St, Abbotsford,
VIC 3067, Australia

Telephone: +61 3 9415 4000

5 – Australian Securities Exchange Limited

Quotation has been granted for all the ordinary shares on all Member Exchanges of the Australian Securities Exchange Limited (ASX):

ASX: CUV.

The Company’s shares are also traded on:

Börse Frankfurt, Germany, under the code UR9; and
Over-the-Counter Market, USA, as a Level 1, American Depositary Receipt (ADR), under the code CLVLY. Each ADR of the Company is equivalent to one ordinary share of the Company, as traded on the ASX. The Bank of New York Mellon is the depositary bank.

6 – Restricted Securities

Restricted securities on issue at 30 June, 2024:

Nil.

7 – Directory

Non-Executive Chair

Prof. Jeffrey Rosenfeld.

Non-Executive Directors

Brenda Shanahan, Dr Karen Agersborg, Susan Smith.

Managing Director And Chief Executive Officer

Dr Philippe Wolgen

Chief Scientific Officer

Dr Dennis Wright

Chief Financial Officer

Peter Vaughan.

Auditor

Grant Thornton Australia Limited
Collins Square, Tower 5, Level 22, 727 Collins Street,
Melbourne, VIC 3008, Australia

Bankers

National Australia Bank (NAB)
Western Branch, 460 Collins St,
Melbourne, VIC 3000, Australia

J. P. Morgan Chase & Co. (JPM)
85 Castlereagh Street,
Sydney, NSW 2000, Australia

Legal Counsel

Arnold Bloch Leibler
Level 21, 333 Collins St,
Melbourne, VIC 3000, Australia

Sidley Austin LLP
Woolgate Exchange, 25 Basinghall Street,
London, EC2V 5HA, United Kingdom

IP Lawyer

Dipl.-Ing Peter Farago
Baadestr 3, Munich 80, Germany

8 – Annual General Meeting

CLINUVEL PHARMACEUTICALS LTD (“Company”) provides notice for its 2024 Annual General Meeting (AGM) of shareholders, which is scheduled to take place on Wednesday 16 October 2024 commencing at 10.00 am (AEDT).

The Notice of Meeting will be lodged with the ASX no later than Friday 13 September 2024. Details in relation to the AGM, including shareholder participation, will be included in the Notice of Meeting and accompanying materials.

In accordance with ASX Listing Rule 3.13.1, the Closing Date for receipt of Director nominations is Thursday 5 September 2024.